Phio Pharmaceuticals
PHIO
#10804
Rank
C$17.15 M
Marketcap
C$1.48
Share price
1.92%
Change (1 day)
-49.68%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -C$15.09 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$12.12 Million a decrease over its 2024 earnings that were of -C$9.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$15.09 Million24.56%
2025 -C$12.12 Million21.65%
2024 -C$9.96 Million-33.96%
2023 -C$15.08 Million-5.7%
2022 -C$15.99 Million-13.6%
2021 -C$18.51 Million51.09%
2020 -C$12.25 Million-1.28%
2019 -C$12.41 Million21.03%
2018 -C$10.26 Million-53.1%
2017 -C$21.86 Million74.49%
2016 -C$12.53 Million-12.02%
2015 -C$14.24 Million16.17%
2014 -C$12.26 Million-57.95%
2013 -C$29.15 Million62.45%
2012 -C$17.95 Million0.87%
2011 -C$17.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.32 Billion 1,994.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.29 Million 66.08%๐Ÿ‡บ๐Ÿ‡ธ USA